A detailed history of Triodos Investment Management Bv transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Triodos Investment Management Bv holds 509,258 shares of EW stock, worth $38.4 Million. This represents 2.74% of its overall portfolio holdings.

Number of Shares
509,258
Previous 407,958 24.83%
Holding current value
$38.4 Million
Previous $37.7 Million 10.82%
% of portfolio
2.74%
Previous 3.31%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$59.7 - $93.78 $6.05 Million - $9.5 Million
101,300 Added 24.83%
509,258 $33.6 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $2.88 Million - $3.79 Million
39,700 Added 10.78%
407,958 $39 Million
Q4 2023

Feb 08, 2024

SELL
$61.71 - $77.76 $370,260 - $466,560
-6,000 Reduced 1.6%
368,258 $28.1 Million
Q3 2023

Nov 07, 2023

SELL
$69.28 - $93.38 $1.16 Million - $1.56 Million
-16,742 Reduced 4.28%
374,258 $25.9 Million
Q2 2023

Aug 09, 2023

SELL
$81.41 - $94.33 $223,877 - $259,407
-2,750 Reduced 0.7%
391,000 $36.9 Million
Q1 2023

May 10, 2023

SELL
$74.26 - $84.51 $371,300 - $422,550
-5,000 Reduced 1.25%
393,750 $32.6 Million
Q4 2022

Feb 08, 2023

SELL
$68.3 - $87.44 $4.17 Million - $5.34 Million
-61,100 Reduced 13.29%
398,750 $29.8 Million
Q3 2022

Nov 09, 2022

BUY
$82.37 - $107.29 $4.06 Million - $5.29 Million
49,300 Added 12.01%
459,850 $38 Million
Q2 2022

Aug 08, 2022

BUY
$86.5 - $128.27 $64,875 - $96,202
750 Added 0.18%
410,550 $39 Million
Q4 2021

Feb 08, 2022

BUY
$106.37 - $130.68 $1.4 Million - $1.72 Million
13,200 Added 3.33%
409,800 $53.1 Million
Q3 2021

Nov 10, 2021

SELL
$102.91 - $122.75 $720,370 - $859,250
-7,000 Reduced 1.73%
396,600 $44.9 Million
Q2 2021

Jul 20, 2021

BUY
$83.84 - $104.76 $100,608 - $125,712
1,200 Added 0.3%
403,600 $41.8 Million
Q1 2021

May 11, 2021

BUY
$78.68 - $90.67 $2.2 Million - $2.54 Million
28,000 Added 7.48%
402,400 $33.7 Million
Q4 2020

Feb 10, 2021

BUY
$71.69 - $91.23 $1.04 Million - $1.32 Million
14,500 Added 4.03%
374,400 $34.2 Million
Q3 2020

Nov 09, 2020

BUY
$67.19 - $87.44 $5.2 Million - $6.77 Million
77,400 Added 27.4%
359,900 $28.7 Million
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $10.2 Million - $13.7 Million
177,400 Added 168.79%
282,500 $19.5 Million
Q1 2020

May 04, 2020

BUY
$52.41 - $81.0 $1.27 Million - $1.97 Million
24,300 Added 30.07%
105,100 $19.8 Million
Q4 2019

Feb 04, 2020

SELL
$71.7 - $82.09 $43,020 - $49,254
-600 Reduced 0.74%
80,800 $18.9 Million
Q3 2019

Nov 05, 2019

SELL
$61.55 - $75.43 $1.76 Million - $2.16 Million
-28,600 Reduced 26.0%
81,400 $17.9 Million
Q2 2019

Jul 30, 2019

SELL
$55.74 - $64.41 $496,086 - $573,249
-8,900 Reduced 7.49%
110,000 $20.3 Million
Q1 2019

May 13, 2019

SELL
$47.89 - $64.05 $541,157 - $723,765
-11,300 Reduced 8.68%
118,900 $22.7 Million
Q4 2018

Feb 07, 2019

SELL
$46.41 - $56.94 $1.68 Million - $2.07 Million
-36,300 Reduced 21.8%
130,200 $19.9 Million
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $388,450 - $493,255
-8,500 Reduced 4.86%
166,500 $29 Million
Q2 2018

Aug 10, 2018

BUY
$42.45 - $51.3 $7.43 Million - $8.98 Million
175,000 New
175,000 $25.5 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Triodos Investment Management Bv Portfolio

Follow Triodos Investment Management Bv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triodos Investment Management Bv, based on Form 13F filings with the SEC.

News

Stay updated on Triodos Investment Management Bv with notifications on news.